XTIA: CEO Scott Pomeroy Granted 2.62M Options at $2
Scott Pomeroy, identified as Director and Chief Executive Officer of XTI Aerospace, Inc. (XTIA), acquired 2,621,100 stock options on 09/04/2025.
Rhea-AI Filing Summary
Scott Pomeroy, identified as Director and Chief Executive Officer of XTI Aerospace, Inc. (XTIA), acquired 2,621,100 stock options on 09/04/2025. The filing shows the award as an acquisition of derivative securities under the companys Amended and Restated 2018 Employee Stock Incentive Plan. One-third of the options vested on the grant date and the remainder vests in equal quarterly installments over two years. The options reference an exercise price of $2 and an expiration date of 09/04/2035. The filing is signed by an attorney-in-fact on behalf of Mr. Pomeroy.
Positive
- Options granted under the companys Amended and Restated 2018 Employee Stock Incentive Plan, indicating a pre-established compensation framework.
- One-third of the options vested on the grant date, providing immediate alignment between the CEO and shareholders.
Negative
- Large option award of 2,621,100 shares could be dilutive depending on the companys outstanding share count (outstanding shares not disclosed in this filing).
- Filing lacks contextual metrics such as total outstanding shares, grant valuation, or percentage of ownership change, limiting assessment of materiality.
Insights
TL;DR: A CEO/director option grant of 2.62M shares was recorded with partial immediate vesting under the company's 2018 incentive plan.
The Form 4 documents a sizeable equity award to the reporting person who serves as both Director and CEO, with one-third vesting immediately and the remainder vesting quarterly over two years. The options carry an exercise-price reference of $2 and an expiration in 2035, and they were granted under the issuers Amended and Restated 2018 Employee Stock Incentive Plan. This is a standard disclosure of insider compensation activity required under Section 16; the filing itself does not include additional context such as total outstanding shares or potential dilution percentages.
TL;DR: The award structure mixes immediate and time-based vesting, aligning short-term and multi-year retention incentives.
The option grant shows a typical mix of immediate vesting (one-third) and continued vesting over two years, which combines immediate reward with retention-based incentives. The instrument is a stock option with an exercise-price reference of $2 and an expiration date of 09/04/2035. The Form 4 notes the grant was made under the companys 2018 plan. The filing does not disclose grant valuation, accounting treatment, or the impact on outstanding share count.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy Common Stock) | 2,621,100 | $0.00 | $0.00 |
Footnotes (2)
- F1. One-third of the stock options vested on the grant date, and the remainder will vest in equal quarterly installments over a two year period.
- F2. The stock options were granted under the Issuer's Amended and Restated 2018 Employee Stock Incentive Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who filed the Form 4 for XTIA and what is their role?
What was granted to Scott Pomeroy on 09/04/2025?
What are the vesting and expiration terms shown in the filing?
What is the exercise price for the options reported on the Form 4?
Under what plan were the options granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.